Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Cash from Financing Activities (2023 - 2025)

Vsee Health's Cash from Financing Activities history spans 3 years, with the latest figure at $6.7 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 587.93% year-over-year to $6.7 million; the TTM value through Dec 2025 reached $8.4 million, up 237.28%, while the annual FY2025 figure was $8.4 million, 39.73% up from the prior year.
  • Cash from Financing Activities reached $6.7 million in Q4 2025 per VSEE's latest filing, up from $943012.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $6.7 million in Q4 2025 to a low of $70000.0 in Q2 2023.
  • Average Cash from Financing Activities over 3 years is $1.1 million, with a median of $393186.5 recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 1296.9% in 2024, then tumbled 34.85% in 2025.
  • A 3-year view of Cash from Financing Activities shows it stood at $70000.0 in 2023, then surged by 1296.9% to $977832.0 in 2024, then skyrocketed by 587.93% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for VSEE's Cash from Financing Activities are $6.7 million (Q4 2025), $943012.0 (Q3 2025), and $209667.0 (Q2 2025).